| Schedule of research and development expenses |
In Thousands of US Dollars | | | For the Year Ended December 31, | | Research and Development Program | | 2025 | | | 2024 | | | 2023 | | Research and Development Program | | $ | - | | | $ | - | | | $ | - | | Alzheimer’s Disease: Therapeutics | | | - | | | | - | | | | - | | Anti-Infectives | | | - | | | | - | | | | - | | BPH (Enlarged Prostate) and Prostate Cancer Therapeutics | | | 1,223 | | | | 2,910 | | | | 2,763 | | Tobacco Exposure Tests: NicAlert™ and TobacAlert™ | | | - | | | | - | | | | - | | Total | | $ | 1,223 | | | $ | 2,910 | | | $ | 2,763 | |
|